Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C

Diabetes

Volumn 49, Issue 1, 2000, Pages 87-93

  Osicka, Tanya M ^a   Yu, Yunxia ^a   Panagiotopoulos, Sianna ^a   Clavant, Steven P ^b   Kiriazis, Zafira ^b   Pike, Robert N ^b   Pratt, Lynette M ^b   Russo, Leileata M ^b   Kemp, Bruce E ^c   Comper, Wayne D ^b   Jerums, George ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINOGUANIDINE; CATHEPSIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; PROTEIN KINASE C; RAMIPRIL; STREPTOZOCIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLOMERULUS; GLOMERULUS FILTRATION RATE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RADIOIMMUNOASSAY; RAT; STREPTOZOCIN DIABETES;

EID: 0033957344     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.1.87     Document Type: Article

References (44)

1. Mogensen CE, Christensen CK, Vittinghus E: The stages in diabetic renal disease: with emphasis on the stage of incipient diabetic nephropathy. Diabetes 32:64-78, 1983
2. Osicka TM, Panagiotopoulos S, Jerums G, Comper WD: Fractional clearance of albumin is influenced by albumin degradation. Clin Sci 93:557-564, 1997
3. Burne MJ, Panagiotopoulos S, Jerums G, Comper WD: Alterations in renal degradation of albumin in early experimental diabetes in the rat: a new factor in the mechanism of albuminuria. Clin Sci 95:67-72, 1998
4. Zamparo O, Comper WD: Model anionic polysaccharide matrices exhibit lower charge selectivity than is normally associated with kidney ultrafiltration. Biophys Chem 38:167-178, 1990
5. Osicka TM, Pratt LM, Comper WD: Glomerular capillary wall permeability to albumin and horseradish peroxidase. Nephrology 2:199-212, 1996
6. Vyas SV, Burne MJ, Pratt LM, Comper WD: Glomerular processing ofdextran sulfate during transcapillary transport. Arch Biochem Biophys 332:205-212, 1996
7. Burne MJ, Adal Y, Cohen N, Panagiotopoulos S, Jerums G, Comper WD: Anomalous decrease in dextran sulfate fractional clearance in the diabetic rat kidney. Am J Physiol 43:F700-F708, 1998
8. Osicka TM, Comper WD: Tubular inhibition destroys charge selectivity for anionic and neutral horseradish peroxidase. Biochim Biophys Acta 1381:170-178, 1998
9. Eppel GA, Osicka TM, Pratt LM, Jablonski P, Howden B, Glasgow EF, Comper WD: The return of glomerular filtered albumin to the rat renal vein. Kidney Int 55:1861-1870, 1999
10. Osicka TM, Comper WD: Protein degradation during renal passage in normal kidneys is inhibited in experimental albuminuria. Clin Sci 93:65-72, 1997
11. Bucala R, Vlassara H: Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis 26:875-888, 1995
12. Cooper ME, Rumble J, Komers R, Du HC, Jandeleit K, Chou ST: Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition. Diabetes 43:1221-1228, 1994
13. Williams B: Glucose-induced vascular smooth muscle dysfunction: the role of protein kinase G. J Hypertens 13:477-486, 1995
14. King GL, Ishii H, Koya D: Diabetic vascular dysfunctions: a model of excessive activation of protein kinase C. Kidney Int 52 (Suppl. 60):S77-S85, 1997
15. Gekle M, Mildenberger S, Freudinger R, Schwerdt G, Silbernagl S: Albumin endocytosis in OK cells: dependence on actin and microtubules and regulation by protein kinases. Am J Physiol 272:F668-F677, 1997
16. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clemont A, Bursell S-E, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 272:728-731, 1996
17. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL: Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89:11059-11063, 1992
18. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL: Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 265:E783-E793, 1993
19. Kunisaki M, Bursell SE, Clermont AC, Ishii H, Ballas LM, Jirousek MR, Umeda F, Nawata H, King GL: Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 269:E239-E264, 1995
20. Koya D, Lee I-K, Ishii H, Kanoh H, King GL: Prevention of glomeruli dysfunction in diabetic rats by treatment with d-α-tocopherol. J Am Soc Nephrol 8:426-435, 1997
21. DeRubertis FR, Craven PA: Activation of protein kinase C in glomerular cells in diabetes: mechanisms and potential link to the pathogenesis of diabetic glomerulopathy. Diabetes 43:1-8, 1994
22. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261:F571-F577, 1991
23. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
24. Malhotra A, Reich D, Reich D, Nakouzi A, Sanghi V, Geenen DL, Buttrick PM: Experimental diabetes is associated with functional activation of protein kinase C epsilon and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade. Circ Res 81:1027-1033, 1997
25. Soulis-LiparotaT, Cooper M, Papazoglou D, Clarke B, Jerums G: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 40: 1328-1334, 1991
26. Soulis T, Cooper ME, Vranes D, Bucala V, Jerums G: Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment. Kidney Int 50:627-634, 1996
27. Allen TJ, Cao Z, Youssef S, Hulthen LU, Cooper ME: Role of angiotensin II and bradykinin in experimental diabetic nephropathy: functional and structural studies. Diabetes 46:1612-1618, 1997
28. Bunag RD: Validation in awake rats of a tail-cuff method for measuring systolic blood pressure. J Appl Physiol 34:279-282, 1973
29. Cefalu WT, Wang ZQ, Bell-Fallow A, Kiger FD, Izlar C: Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia. Clin Chem 40:1317-1321, 1994
30. O'Brien RC, Allen TJ, Cooper ME, Bach LA, Jerums G: Glomerular filtration rate in early experimental diabetes. J Diabetes Complications 2:8-11, 1988
31. Soulis-Liparota T, Cooper ME, Dunlop M, Jerums G: The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia 38:387-394, 1995
32. Tack BF, Dean J, Eilat D, Lorenz PE, Schecter AN: Tritium labelling of proteins to high specific radioactivity by reductive methylation. J Biol Chem 255:8842-8847, 1980
33. Spiro RG: Studies on the renal glomerular basement membrane: preparation and chemical composition. J Biol Chem 242:1915-1922, 1967
34. Heasley LE, Johnson GL: Regulation of protein kinase C by nerve growth factor, epidermal growth factor, and phorbol esters in PC12 pheochromocytoma cells. J Biol Chem 264:8646-8652, 1989
35. Harikumar P, Reeves JP: The lysosomal pump is electrogenic. J Biol Chem 258:10403-10410, 1983
36. Barrett AJ, Kirschke H: Cathepsin B, cathepsin H and cathepsin L. In Methods in Enzymology. Vol. 80. Lerand L, Ed. San Diego, Academic, 1981, p. 535-561
37. Read SM, Northcote DH: Minimization of variation in the response to different proteins of the Coomassie Blue dye-binding assay for protein. Anal Biochem 116:53-64, 1981
38. Li YM, Mitsuhashi T, Wojciechowicz D, Shimizu N, Li J, Stitt A, He C, Banerjee D, Vlassara H: Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc Natl Acad Sci U S A 93:11047-11052, 1996
39. Han HJ, Koh HJ, Park SH: A signaling pathway for stimulation for Na+ uptake induced by angiotensin II in primary cultured rabbit renal proximal tubule cells. J Vet Med Sci 61:135-141, 1999
40. Hunziker W, Male P, Mellman I: Differential microtubule requirements for transcytosis in MDCK cells. EMBO 9:3515-3525, 1990
41. Nerurkar MA, Satav JG, Katyare SS: Insulin-dependent changes in lysosomal cathepsin D activity in rat liver, kidney, brain and heart. Diabetologia 31:119-122, 1988
42. Olbricht CJ, Geissinger B: Renal hypertrophy in streptozotocin diabetic rats: role of proteolytic lysosomal enzymes. Kidney Int 41:966-972, 1992
43. Radons J, Biewusch U, Grässel S, Geuze HJ, Hasilik A: Distinctive inhibition of the lysosomal targeting of lysozyme and cathepsin D by drugs affecting pH gradients and protein kinase C. Biochem J 302:581-586, 1994
44. Gewer K, Tapper H, Nauclér C, Sundler R: Dexamethasone downregulates lysosomal secretion in mouse macrophages: involvement of signaling through protein kinase C. J Inflamm 47:115-125, 1995/1996